Teligent Pharma, Inc. is recalling 7,488 bottles of Erythromycin Topical Solution USP, 2% (60mL), a prescription medication used to treat skin conditions. The recall was initiated because the containers may be defective, which could lead to a lack of seal integrity for the bottle. Consumers who have this medication should check their bottle's lot number and contact their healthcare provider or pharmacist for guidance regarding the continued use of the product.
A compromised seal on the medication bottle can lead to product leakage, evaporation, or potential contamination of the solution, which may reduce the effectiveness of the treatment or cause skin irritation.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.